The COMPERA 2.0 study reported a four-tier risk stratification model for patients with pulmonary arterial hypertension (PAH). The authors are from numerous institutions in Europe.
Patient selection: adult with mean age 61 +/- 15 years with pulmonary arterial hypertension
Parameters:
(1) WHO functional class for PAH
(2) 6MWD in meters
(3) serum BNP in ng/L
(4) serum NT-proBNP in ng/L
Parameter |
Finding |
Points |
WHO functional class |
I or II |
1 |
|
III |
3 |
|
IV |
4 |
6MWD |
> 440 meters |
1 |
|
320 to 440 meters |
2 |
|
165 to 320 meters |
3 |
|
< 165 meters |
4 |
serum BNP |
< 50 ng/L |
1 |
|
50 to 199 ng/L |
2 |
|
200 to 800 ng/L |
3 |
|
> 800 ng/L |
4 |
serum NT-proBNP |
< 300 ng/L |
1 |
|
300 to 649 ng/L |
2 |
|
650 to 1,100 ng/L |
3 |
|
> 1,100 ng/L |
4 |
total score =
= SUM(points for all of the parameters)
average score =
= (total score) / 4
Interpretation:
• minimum total score: 4
• maximum total score: 16
• minimum average score: 1
• maximum average score: 4
• The prognosis varied between baseline and follow-up assessments.
Average Score |
Risk |
5-Year Survival (baseline score) |
< 1.5 |
low |
75% |
1.5 to 2.49 |
intermediate-low |
65% |
2.5 to 3.49 |
intermediate-high |
44% |
>= 3.50 |
high |
31% |
Specialty: Pulmonology